Monthly Communication Reports in:
February
2023
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Cystic Fibrosis Canada/Fibrose kystique Canada
Kelly
Grover,
President and Chief Executive Officer
(Organization)
-
Cystic Fibrosis Canada
In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jeff Waring,
Chief of Operations, Privy Council Office
|
Privy Council Office (PCO)
-
Daniel MacDonald,
Director General, Drugs for Rare Diseases
|
Health Canada (HC)
-
Michelle Mujoombar,
Director, Specialty Pharmaceuticals
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-02-16
Posted date:
2023-03-15
Communication number:
266824-558255
View associated registration